Security record · archived quarter
HCA
HCA Healthcare, Inc. · Healthcare · Medical - Care Facilities
3Tracked holders
0Δ holders
66.96KShares held
$27.12MReported value
+0New positions
−2Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 66.96K | $27.12M | n/a | −2 |
| Q2 2026 | 161 | -3 | 97.44M | $37.99B | +4 | −9 |
| Q1 2026 | 169 | +3 | 106.88M | $50.54B | +5 | −3 |
| Q4 2025 | 165 | -1 | 114.61M | $53.42B | +1 | −1 |
| Q3 2025 | 26 | +1 | 64.51M | $27.48B | +1 | −1 |
| Q2 2025 | 23 | +1 | 60.26M | $23.08B | +1 | n/a |
| Q1 2025 | 19 | -2 | 30.59M | $10.56B | +1 | −3 |
| Q4 2024 | 21 | 0 | 31.21M | $9.36B | +1 | −1 |
| Q3 2024 | 20 | -1 | 22.69M | $9.21B | +1 | −2 |
| Q2 2024 | 21 | n/a | 27.53M | $8.84B | n/a | n/a |
Who holds it · Q3 2026
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wealth Enhancement Advisory… | 35.01K | +13.2% | $13.53M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Assenagon Asset Management S.A. | 19.16K | -36.1% | $8.18M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | TD Waterhouse Canada Inc. | 12.79K | -18.2% | $5.42M | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Assetmark, Inc | $15.13M | was 0.0% |
| Robeco Institutional Asset… | $8.35M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,403 holders, 128.02M shares, $58.43B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2026 ·
Methodology ·
Get this via the API